Wade J. Sexton, MD

BOARD CERTIFICATION:
          •  Urology

FELLOWSHIP:
          •  The University of Texas, MD Anderson Cancer Center - Urologic Oncology

RESIDENCY:
          •  Wake Forest University, Winston-Salem, NC - Urology
          •  Wake Forest University, Winston-Salem, NC - Surgery

MEDICAL SCHOOL:
          •  Emory University School of Medicine - MD

• Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M. Penile cancer. J Natl Compr Canc Netw. 2013 May;11(5):594-615. Pubmedid: 23667209.


• Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M. Bladder cancer. J Natl Compr Canc Netw. 2013 Apr;11(4):446-475. Pubmedid: 23584347.


• Sexton WJ. Editorial Comment. Urology. 2013 Apr;81(6):1244. Pubmedid: 23608665.


• Sexton WJ. Editorial comment. J Urol. 2013 Jan;189(1 Suppl):S18. Pubmedid: 23234623.


• Rao SR, Correa JJ, Sexton WJ, Pow-Sang JM, Dickinson SI, Lin HY, Spiess PE. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2012 Dec;110(11 pt B):E475-E480. Pubmedid: 22564727.


• Spiess PE, Kurian T, Lin HY, Rawal B, Kim T, Sexton WJ, Pow-Sang JM. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy. BJU Int. 2012 Dec;110(11 pt B):E470-E474. Pubmedid: 22519938.


• Lawindy SM, Kurian T, Kim T, Mangar D, Armstrong PA, Alsina AE, Sheffield C, Sexton WJ, Spiess PE. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int. 2012 Oct;110(7):926-939. Pubmedid: 22540179.


• Buethe DD, Moussly S, Lin HY, Yue B, Rodriguez AR, Spiess PE, Sexton WJ. Is the R.E.N.A.L. nephrometry scoring system predictive of the functional efficacy of nephron sparing surgery in the solitary kidney?. J Urol. 2012 Sep;188(3):729-735. Pubmedid: 22819418.


• Seifert RP, McNab P, Sexton WJ, Sawczyn KK, Smith P, Coppola D, Bui MM. Rhabdomyomatous differentiation in wilms tumor pulmonary metastases: a case report and literature review. Ann Clin Lab Sci. 2012;42(4):409-416. Pubmedid: 23090738.


• Kolla SB, Spiess PE, Sexton WJ. Interobserver reliability of the RENAL nephrometry scoring system. Urology. 2011 Sep;78(3):592-594. Pubmedid: 21782219.


• Caso J, Tidwell J, Tsivian M, Sexton WJ. Stapled renal vein with in situ tumor thrombus: a useful intraoperative maneuver to facilitate radical nephrectomy and inferior vena cava thrombectomy. Urology. 2011 Jan;77(1):217-222. Pubmedid: 20472275.


• Buethe DD, Sexton WJ. Bladder cancer: Validating the EORTC risk tables in BCG-treated patients. Nat Rev Urol. 2011;8(9):480-481. Pubmedid: 21844905.


• Kolla SB, Ercole C, Spiess PE, Pow-Sang JM, Sexton WJ. Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein. BJU Int. 2010 Nov;106(10):1494-1498. Pubmedid: 20230378.


• Sexton WJ, Wiegand LR, Correa JJ, Politis C, Dickinson SI, Kang LC. Bladder cancer: a review of non-muscle invasive disease. Cancer Control. 2010 Oct;17(4):256-268. Pubmedid: 20861813.


• Sexton WJ, Spiess PE, Pisters LL, Carpenter S, Madsen LT, Zagone R, Wang X, Troncoso P. Are there differences in zonal distribution and tumor volume of prostate cancer in patients with a positive family history?. Int Braz J Urol. 2010 Sep-Oct;36(5):571-582. Pubmedid: 21044374.


• Thomas CE, Sexton W, Benson K, Sutphen R, Koomen J. Urine collection and processing for protein biomarker discovery and quantification. Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(4):953-959. Pubmedid: 20332277. Pmcid: PMC2852495.


• Caso J, Qin D, Sexton WJ. Eosinophilic cystitis following immediate post-resection intravesical instillation of mitomycin-C. Can J Urol. 2010 Jun;17(3):5223-5225. Pubmedid: 20566021.


• Sexton WJ. Editorial comment. J Urol. 2010 Mar;183(3):969-. Pubmedid: 20089275.


• Caso J, Seigne J, Back M, Spiess PE, Pow-Sang J, Sexton WJ. Circumferential resection of the inferior vena cava for primary and recurrent malignant tumors. J Urol. 2009 Sep;182(3):887-893. Pubmedid: 19616230.


• Moul J, Wu H, Sun L, McLeod D, Amling C, Donahue T, Kusuda L, Sexton W, O'Reilly K, Hernandez J, Chung A, Soderdahl D. Early versus delayed hormonal therapy for prostate specific antigen onlyrecurrence of prostate cancer after radical prostatectomy. J Urol. 2008 May;179(5 Suppl):S53-S59. Pubmedid: 18405753.


• Whittemore D, Hick E, Carter M, Moul J, Miranda-Sousa A, Sexton W. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens. J Urol. 2008 Feb;179(2):516-522. Pubmedid: 18076949.


• Al-Qudah H, Rodriguez A, Sexton W. Laparoscopic management of kidney cancer: updated review. Cancer Control. 2007 Jul;14(3):218-230. Pubmedid: 17615527.


• Rollison DE, Sexton WJ, Rodriguez AR, Kang LC, Daniel R, Shah KV. Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer. 2007 Mar;120(6):1248-1251. Pubmedid: 17192899.


• Montie J, Abrahams N, Bahnson R, Eisenberger M, El-Galley R, Herr H, Hudes G, Kuzel T, Lange P, Patterson A, Pollack A, Richie J, Sexton W, Shipley W, Small E, Trump D, Walther P, Wilson T. Bladder cancer. Clinical guidelines in oncology. J Natl Compr Canc Netw. 2006 Nov;4(10):984-1014. Pubmedid: 17112448.


• Morey A, Evans L, McDonough RC 3rd, Park A, Sexton W, Basler J, SantucciRA, Amling C, O'Reilly K. Evaluation of mechanical bowel preparation methods in urinary diversion surgery. Can J Urol. 2006 Oct;13(5):3250-3254. Pubmedid: 17076946.


• Rodriguez A, Sexton W. Management of locally advanced renal cell carcinoma. Cancer Control. 2006 Jul;13(3):199-210. Pubmedid: 16885916.


• Rodriguez A, Kang L, Politis C, Wade M, Sexton W, Miranda-Sousa A, Pow-Sang JM. Delayed metastatic renal carcinoma to prostate. Urology. 2006 Mar;67(3):623-623. Pubmedid: 16527593.


• Rodriguez A, Burday D, Sexton W, Ahmad N, Pow-Sang J. Urothelial carcinoma in a child. Arch Esp Urol. 2005 Jun;58(5):473-475. Pubmedid: 16078794.


• Baughman S, Sexton W, Glanton C, Dalrymple N, Bishoff J. Computerized tomography guided radio frequency ablation of a renal cell carcinoma within a renal allograft. J Urol. 2004 Oct;172(4 Pt 1):1262-1263. Pubmedid: 15371819.


• Wu H, Sun L, Moul J, Wu H, McLeod D, Amling C, Lance R, Kusuda L, DonahueT, Foley J, Chung A, Sexton W, Soderdahl D. Watchful waiting and factors predictive of secondary treatment of localized prostate cancer. J Urol. 2004 Mar;171(3):1111-1116. Pubmedid: 14767282.


• Moul J, Wu H, Sun L, McLeod D, Amling C, Donahue T, Kusuda L, Sexton W, O'Reilly K, Hernandez J, Chung A, Soderdahl D. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol. 2004 Mar;171(3):1141-1147. Pubmedid: 14767288.


• Amling C, Riffenburgh R, Sun L, Moul J, Lance R, Kusuda L, Sexton W, Soderdahl D, Donahue T, Foley J, Chung A, McLeod D. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2004 Feb;22(3):439-445. Pubmedid: 14691120.


• Carter C, Donahue T, Sun L, Wu H, McLeod D, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Jackmaan S, Moul J. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. J Clin Oncol. 2003 Nov;21(21):4001-4008. Pubmedid: 14581423.


• Moul J, Sun L, Wu H, McLeod D, Amling C, Lance R, Foley J, Sexton W, KusudaL, Chung A, Soderdahl D, Donahue T. Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national database. Urol Oncol. 2003 Nov;21(6):447-455. Pubmedid: 14693271.


• Baughman S, Sexton W, Bishoff J. Multiple intravesical linear staples identified during surveillance cystoscopy after laparoscopic nephroureterectomy. Urology. 2003 Aug;62(2):351-351. Pubmedid: 12893356.


• Massengill J, Sun L, Moul J, Wu H, McLeod D, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Donahue T. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol. 2003 May;169(5):1670-1675. Pubmedid: 12686805.


• Sexton W, Wood C, Kim R, Pisters L. Repeat retroperitoneal lymph node dissection for metastatic testis cancer. J Urol. 2003 Apr;169(4):1353-1356. Pubmedid: 12629359.


• Moul J, Wu H, Sun L, McLeod D, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D, Rich N. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database. Surgery. 2002 Aug;132(2):213-219. Pubmedid: 12219014.


• Sexton W, Lance R, Reyes A, Pisters P, Tu S, Pisters L. Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience. J Urol. 2001 Aug;166(2):521-525. Pubmedid: 11458058.


• Holmes R, Sexton W, Applewhite J, Kennedy M, Assimos D. Glycolate metabolism by Hep G2 cells. J Am Soc Nephrol. 1999 Nov;10:S345-S347. Pubmedid: 10541260.


• Sexton W, Assimos D. Diagnostic and therapeutic laparoscopy for the adult cryptorchid testicle. Tech Urol. 1999 Mar;5(1):24-28. Pubmedid: 10374791.


• Sexton W, Benedict J, Jarow J. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy. J Urol. 1998 Mar;159(3):811-815. Pubmedid: 09474156.


• Sexton W, Routh W, McCullough D, Bare R. Hypogastric arterial-ureteral fistula. J Urol. 1998 Jan;159(1):196-197. Pubmedid: 09400472.


• Sexton W, Jarow J. Effect of diabetes mellitus upon male reproductive function. Urology. 1997 Apr;49(4):508-513. Pubmedid: 09111618.


• Poore R, Sexton W, Hart L, Assimos D. Is radiographic evaluation of the chest necessary following flank surgery. J Urol. 1996 Mar;155(3):849-851. Pubmedid: 08583591.


• Henderson-Jackson E, Sexton W, Zhang J, Hakam A, Petrovskyy VS, Bui MM, Chuang ST. Cystic prostatic ductal adenocarcinoma: an unusual presentation and cytological diagnosis. Ann Clin Lab Sci. 2012 Winter;42(1):81-88. Pubmedid: 22371914.

Dr. Wade Jeffers Sexton is a genitourinary oncology surgeon and director of the urologic oncology fellowship at Moffitt Cancer Center.  He is also an associate professor of oncology at the University of South Florida.

After receiving his medical degree from Emory University School of Medicine on a U.S. Air Force-sponsored scholarship, Dr. Sexton completed his residency at Wake Forest University-Baptist Medical Center, where he was chief urology resident.   His fellowship training in oncology took place at The University of Texas M.D. Anderson Cancer Center.  

Before coming to Moffitt, Dr. Sexton completed his active duty military service, serving in England and then Texas, where he was director of urologic oncology at Lackland Air Force Base.

Dr. Sexton has a special interest in minimally invasive kidney-sparing procedures, bladder reconstruction and nerve preservation surgery, as well as advanced urologic laparoscopic procedures for kidney, bladder, testis, prostate and penile cancer.  He is a member of the Florida Urologic Society executive committee and a bladder cancer panel member of the National Comprehensive Cancer Network. 

Dr. Sexton was named to Who’s Who in America and Who’s Who in Science and Engineering in 2011.